- COVID-19
- Biosimilars
- Cataract Therapeutics
- DME
- Gene Therapy
- Workplace
- Ptosis
- Optic Relief
- Imaging
- Geographic Atrophy
- AMD
- Presbyopia
- Ocular Surface Disease
- Practice Management
- Pediatrics
- Surgery
- Therapeutics
- Optometry
- Retina
- Cataract
- Pharmacy
- IOL
- Dry Eye
- Understanding Antibiotic Resistance
- Refractive
- Cornea
- Glaucoma
- OCT
- Ocular Allergy
- Clinical Diagnosis
- Technology
Dr. Skuta named president/CEO of McGee Eye Institute
Gregory L. Skuta, MD, has been named president and chief executive officer (CEO) of the Dean McGee Eye Institute, succeeding David W. Parke II, MD, who was appointed executive vice president and CEO of the American Academy of Ophthalmology in San Francisco in 2009.
Oklahoma City, OK
- Gregory L. Skuta, MD, has been named president and chief executive officer (CEO) of the Dean McGee Eye Institute, succeeding David W. Parke II, MD, who was appointed executive vice president and CEO of the American Academy of Ophthalmology in San Francisco in 2009. Dr. Skuta also will serve as chairman of the department of ophthalmology in the University of Oklahoma College of Medicine and will hold the Edward L. Gaylord Endowed Chair.
“Dr. Skuta’s remarkable work as a glaucoma specialist and clinical researcher the past 17 years here at the institute has contributed significantly to our emergence as one of the top ophthalmologic institutions in America,” said James R. Tolbert III, chairman of the institute’s board of trustees.
From 1987 to 1992, Dr. Skuta was a faculty member at the University of Michigan’s W.K. Kellogg Eye Center. He joined the McGee Eye Institute in 1992.
